Are You Looking for a Top Momentum Pick? Why The Pennant Group, Inc. (PNTG) is a Great Choice
Does The Pennant Group, Inc. (PNTG) have what it takes to be a top stock pick for momentum investors? Let's find out.
PNTG - The Pennant Group, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$44.50
DETAILS
HIGH:
$48.00
LOW:
$40.00
MEDIAN:
$45.00
CONSENSUS:
$44.50
UPSIDE:
10.23%
Stock News
The Pennant Group: The Pros Of Investing Continue To Outweigh The Cons
I am maintaining my Buy rating on The Pennant Group driven by robust fundamentals and +200% stock appreciation since April 2023. PNTG delivered 36% revenue growth in 2025 and guides for 25% growth in 2026, with adjusted EPS of $1.34–$1.41 and EBITDA of $94.4–$98M. Strategic acquisitions, disciplined growth, and a culture of operational excellence underpin PNTG's expansion in home health, hospice, and senior living.
The Pennant Group (PNTG) Moves 6.3% Higher: Will This Strength Last?
The Pennant Group (PNTG) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Pennant Acquires Real Estate of Mainplace Senior Living in Orange, California
EAGLE, Idaho, Sept. 16, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of Pennant affiliated home health, hospice, home care and senior living companies, announced today that, effective September 3, 2026, it acquired the real estate of Mainplace Senior Living (“Mainplace”), a senior living community located in Orange, California. A Pennant affiliated subsidiary has operated Mainplace under a triple-net lease since our spin-off in 2019. This acquisition aligns with our disciplined approach of capital deployment in acquiring senior living real estate, at attractive pricing, to capture both the long-term value of the real estate that benefits from the strong cultural, clinical and operational results in the acquired community.
All You Need to Know About The Pennant Group (PNTG) Rating Upgrade to Buy
The Pennant Group (PNTG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Pennant Group to Participate in the 2026 Jefferies Healthcare Services Conference
EAGLE, Idaho, Sept. 01, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it will participate in the upcoming 2026 Jefferies Healthcare Services Conference on September 15, 2026.
BlackRock Inc. Acquires New Shares in The Pennant Group, Inc. $PNTG
BlackRock Inc. acquired a new position in The Pennant Group, Inc. (NASDAQ: PNTG) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 2,959,141 shares of the company's stock, valued at approximately $109,340,000. BlackRock Inc. owned approximately 8.51% of The Pennant Group as of
OPCH vs. PNTG: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Outpatient and Home Healthcare stocks have likely encountered both Option Care (OPCH) and The Pennant Group, Inc. (PNTG). But which of these two stocks offers value investors a better bang for their buck right now?
The Pennant Group Q2 Earnings Call Highlights
The Pennant Group NASDAQ: PNTG reported second-quarter 2026 results that showed revenue and adjusted earnings growth across its home health, hospice and senior living businesses, prompting the company to raise its full-year outlook.
The Pennant Group, Inc. (PNTG) Q2 2026 Earnings Call Transcript
The Pennant Group, Inc. (PNTG) Q2 2026 Earnings Call Transcript
The Pennant Group, Inc. (PNTG) Tops Q2 Earnings and Revenue Estimates
The Pennant Group, Inc. (PNTG) came out with quarterly earnings of $0.36 per share, beating the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.27 per share a year ago.
Pennant Reports Second Quarter 2026 Results
EAGLE, Idaho, Aug. 05, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results, reporting GAAP diluted earnings per share of $0.25 for the second quarter of 2026. Pennant also reported adjusted diluted earnings per share of $0.36 for the quarter(1 ).
Pennant Acquires River Centre Assisted Living in Tucson, Arizona
EAGLE, Idaho, Aug. 04, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of Pennant affiliated home health, hospice, home care and senior living companies, announces today that effective August 1, 2026, it acquired the real estate and operations of Inspirations of River Centre Senior Living, now known as River Centre Assisted Living, an established 63-unit assisted living community located in Tucson, Arizona. Located in a strong and growing market, River Centre Assisted Living brings additional scale and opportunity to Pennant's senior living operations. The community will continue serving residents with a focus on personalized care, meaningful engagement, and a culture centered on local leadership and accountability.
Pennant Announces Second Quarter 2026 Earnings Release and Call
EAGLE, Idaho, July 28, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it expects to issue its second quarter 2026 financial results on Wednesday, August 5, 2026. Pennant invites current and prospective investors to tune into a live webcast to be held the following day, Thursday, August 6, 2026, at 10:00 a.m.
The Pennant Group, Inc. (PNTG) Soars to 52-Week High, Time to Cash Out?
The Pennant Group (PNTG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
DaVita Stock Benefits From Expanding Community-Based Kidney Care
DVA is expanding kidney care through outpatient, home-centered and value-based programs while investing in AI-enabled scheduling.
Here is Why Growth Investors Should Buy The Pennant Group (PNTG) Now
The Pennant Group (PNTG) possesses solid growth attributes, which could help it handily outperform the market.
The Pennant Group and Hartford HealthCare Expand Collaboration to Advance Home-Based Care in Connecticut
EAGLE, Idaho, June 04, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care, and senior living companies, and Hartford HealthCare, a leading integrated health system serving Connecticut, announced the next evolution of their strategic collaboration to strengthen and expand home-based care services across Connecticut.
Pennant Expands Senior Living Presence with Pleasant Hill, California Community
EAGLE, Idaho, June 03, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, today announced that it assumed operations of a senior living community in Pleasant Hill, California, known as Memory Care of Contra Costa, on Monday, June 1. This acquisition marks Pennant's first senior living expansion into California since becoming an independent publicly traded company in 2019.
Wall Street Analysts Believe The Pennant Group (PNTG) Could Rally 27.59%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 27.6% in The Pennant Group (PNTG). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Price Targets
Pennant Group price target raised to $44 from $42 at RBC Capital
$44.00
(was $39.41)
Ben Hendrix
·
RBC Capital
Pennant Group price target raised to $46 from $45 at Wells Fargo
$46.00
(was $39.64)
Wells Fargo
Pennant Group price target raised to $48 from $42 at Truist
$48.00
(was $39.86)
David MacDonald
·
Truist Financial
Pennant Group price target raised to $45 from $41 at Wells Fargo
$45.00
(was $40.50)
Wells Fargo
Pennant Group price target raised to $40 from $37 at Oppenheimer
$40.00
(was $36.00)
Oppenheimer
Pennant Group price target raised to $38 from $31 at Wells Fargo
$38.00
(was $28.59)
Stephen Baxter
·
Wells Fargo
Pennant Group price target raised to $40 from $30 at Jefferies
$40.00
(was $30.23)
Jefferies
Pennant Group price target raised to $39 from $34 at RBC Capital
$39.00
(was $24.90)
RBC Capital
The Pennant Group (PNTG) PT Raised to $38 at RBC Capital
$38.00
(was $33.34)
Frank Morgan
·
RBC Capital
Pennant Group price target raised to $34 from $28 at Truist
$34.00
(was $30.33)
David MacDonald
·
Truist Financial
The Pennant Group (PNTG) PT Raised to $32 at Stephens
$32.00
(was $28.07)
Scott Fidel
·
Stephens
The Pennant Group (PNTG) PT Raised to $25 at Truist Securities
$25.00
(was $22.21)
David MacDonald
·
Truist Financial
The Pennant Group (PNTG) PT Raised to $26 at RBC Capital
$26.00
(was $22.14)
Frank Morgan
·
RBC Capital
Stephens Upgrades The Pennant Group (PNTG) to Overweight, 'Favorable Growth Prospects'
$18.00
(was $15.35)
Scott Fidel
·
Stephens
Pennant Group (PNTG) Stock: $12 Target And Hold Rating
$12.00
(was $13.43)
David MacDonald
·
Truist Financial